Literature DB >> 9198003

Interferon-beta induces S phase accumulation selectively in human transformed cells.

X Q Qin1, L Runkel, C Deck, C DeDios, J Barsoum.   

Abstract

Interferons (IFNs) generally have been characterized as antiproliferative cytokines. The cell cycle arrest in G1/G0 phase induced by type I IFNs, especially IFN-alpha, was recognized as a manifestation of their antiproliferative effects. In this article, we report that the cell cycle block in G1/G0 is observed mainly in certain cell types, such as Daudi Burkitt's lymphoma cells. In a variety of human transformed cells, but not nontransformed primary cells, IFN-beta and IFN-alpha induced a significant increase in the S phase population. The increase appeared to be due to a continued S phase entry and subsequently a failure of S phase cells to transit efficiently into G2 and M phases. The ability of tumor cells to exhibit the S phase effect correlated with proper IFN signaling and loss or inactivation of the normal G1 checkpoint conferred by the retinoblastoma protein (pRB). Overriding the G1 checkpoint switched human nontransformed primary cells from nonresponsive to sensitive to the IFN-induced effect. Therefore, the cell cycle regulatory machinery could function, at least in part, as a determining factor that affects the IFN-induced cell cycle effect. The IFN effect in transformed cells may suggest intriguing prospects for combinatorial therapies for cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9198003     DOI: 10.1089/jir.1997.17.355

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  9 in total

1.  Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.

Authors:  J D Burke; L C Platanias; E N Fish
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

2.  gamma-Glutamyl transpeptidase expression in Ewing's sarcoma cells: up-regulation by interferons.

Authors:  Lena Bouman; Josiane Sancéau; Dany Rouillard; Brigitte Bauvois
Journal:  Biochem J       Date:  2002-06-15       Impact factor: 3.857

Review 3.  Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis.

Authors:  Yi-Wen Huang; Albert Qin; Chan-Yen Tsai; Pei-Jer Chen
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

4.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.

Authors:  C Ren; S Kumar; D Chanda; L Kallman; J Chen; J D Mountz; S Ponnazhagan
Journal:  Gene Ther       Date:  2008-07-03       Impact factor: 5.250

6.  Butyrate augments interferon-alpha-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells.

Authors:  T Miyachi; M Adachi; Y Hinoda; K Imai
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan.

Authors:  Kuan-Yuan Chen; Kang-Yun Lee; Albert Qin; Ching-Shan Luo; Yun-Kai Yeh; Jing-Quan Zheng; Ching-Mei Chen; Chan-Yen Tsai; Sheena Lin; Jason Liao; Yi-Wen Huang; Po-Hao Feng
Journal:  Adv Ther       Date:  2021-12-15       Impact factor: 4.070

8.  A combined antitumor strategy of separately transduced mesenchymal stem cells with soluble TRAIL and IFNβ produces a synergistic activity in the reduction of lymphoma and mice survival enlargement.

Authors:  Adriana G Quiroz-Reyes; Carlos A González-Villarreal; Herminia Martínez-Rodriguez; Salvador Said-Fernández; Mario César Salinas-Carmona; Alberto Y Limón-Flores; Adolfo Soto-Domínguez; Gerardo Padilla-Rivas; Roberto Montes De Oca-Luna; Jose F Islas; Elsa N Garza-Treviño
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 3.423

Review 9.  A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers.

Authors:  George R Nahas; Nykia D Walker; Margarette Bryan; Pranela Rameshwar
Journal:  Breast Cancer (Auckl)       Date:  2015-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.